Bioequivalence to become compulsory for generic combination drugs

From this October, generic combinations drugs produced cheaply in Korea must prove they are equivalent to the patented medicines on which they are modeled, the Korea Food and Drug Administration said on April 27.

The drug agency also said that bioequivalence testing would also be a prerequisite for import of generic combination drugs.

Currently, a total of 600 combination products are on ...